Ranee Mehra, MD


Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment Selection

Ranee Mehra, MD, discusses the link between PD-L1 expression and increased immunotherapy efficacy in head and neck squamous cell carcinoma, and what future treatment options may look like for patients in this space.

Susan Samson, MSN, FNP-C


Advanced Practice Providers Are Uniquely Suited for Survivorship Care

Advanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.

Edgardo Santos, MD, FACP


Unmet Needs and Future Directions in the Management of CIM

Martin Dietrich, MD, PhD, and Edgardo Santos, MD, FACP, offer closing remarks on unmet needs and future directions in the management of CIM including other disease states where trilaciclib may offer myeloprotective benefit.

Russ Conroy


Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC

Nivolumab/Cabozantinib continued to outperform sunitinib in an updated analysis of the phase 3 CheckMate 9ER trial.

Aaron T. Gerds, MD, MS


Aaron Gerds on JAK Inhibitor Therapy for Anemic Patients With Myelofibrosis

Aaron T. Gerds, MD, MS, unpacks data seen with momelotinib for patients with anemic myelofibrosis.

Shari Mycek


Discrepancies Exist Between Actual Care and Trial-Based Recommendations in MCL

Discrepancies exist between actual patterns of care and recommendations based on clinical trials in adult patients with mantle cell lymphoma.

Jordyn Sava


Addition of Abemaciclib to Aromatase Inhibitor Therapy Prolongs Survival in HR+/HER2- Breast Cancer

For patients receiving an aromatase inhibitor for hormone receptor–positive, HER2-negative breast cancer, the addition of abemaciclib doubled median progression-free survival vs placebo.

Kristin Barber, APRN, AOCNP, FNP-BC


Durvalumab Outcomes Could Change Treatment Approaches in Cholangiocarcinoma

Adding the immunotherapy to chemotherapy in the frontline setting may improve overall survival for patients with advanced biliary tract cancer.

Lindsay Fischer


Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.

Julie McGuire RN, MSN


Opinion: Now Is the Time to Optimize Electronic Health Record Systems

Buying one for your practice or enhancing the one you have will help you cut costs and boost your financial stability.

Kristin M. Daly, MSN, ANP-BC, AOCNP


Kristin Daly on the Difference Between Somatic and Germline Variants in Precision Oncology

Kristin M. Daly, MSN, ANP-BC, AOCNP, highlights the difference between somatic and germline variants.

Cleveland Clinic


Cleveland Clinic Opens New Cancer Center in Abu Dhabi

The state-of-the-art facility represents the organization’s vision of global cancer care

Josh Weiner


COVID-19 and the Rise of Texting in Health Care

The last thing patients want is to be put on hold or interrupted by calls at work.

Marlee Kiel, LCSW


How Social Media Helps AYA Patients With Cancer Find Support

The rise of social media platforms has helped foster a community for adolescent and young adult patients with cancer.

Christine Wylie, MSN, RN, OCN


Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast Cancer

Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.

Ariana Pelosci


Capivasertib/Fulvestrant Boosts Progression-Free Survival in HR+/HER2– Breast Cancer

Capivasertib plus fulvestrant improved progression-free survival in patients who have hormone-receptor–positive/HER2-negative advanced breast cancer.

Sailaja Darisipudi


Improved PFS Outcomes With Elacestrant Correlate With CDK4/6 Duration in ER+/HER2– Metastatic Breast Cancer

Longer duration of CDK4/6 inhibitor prior to treatment with elacestrant correlated with progression-free survival (PFS) improvements in patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer vs standard-of-care options.

Paul Nathan, PhD


Newly Approved Tebentafusp Requires Up-Front Active Toxicity Management in Melanoma

Tebentafusp, the first FDA-approved treatment option for patients with unresectable or metastatic uveal melanoma, may cause mild cytokine release syndrome, an expert explains.



Eric Zack on Disseminated Intravascular Coagulation Prevention and Management

Eric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, describes disseminated intravascular coagulation and best nursing strategies to mitigate the severity of this condition.

Michigan State University


Hospice Professionals Use Mind, Body, and Movement Meditation to Reduce Stress

A program evaluated at Michigan State University has shown that meditation helps combat burnout and promote well-being among health care workers, particularly in hospice settings.

La-Urshalar Brock, MSN, FNP-BC, CNM


La-Urshalar Brock on Testing for HER2 in Patients with Metastatic Breast Cancer

La-Urshalar Brock, MSN, FNP-BC, CNM, discusses HER2 status and its implications for patients with breast cancer.

Uma Naidoo, MD


Health Care Professionals Can Fight Burnout Through Their Diet

“This is a holistic, functional and integrative approach to your mental well-being. So, you start small, and you build up on that. It is not an overnight fix; it is a slow and steady progress.”

Carla Schaefer, DNP, RN, OCN, CENP


Nursing Education Can Be a Lifelong Marathon. Are You Ready for the Race?

Nursing education should be viewed as a long-course endeavor rather than a sprint.

Alyssa Ridad, BSN-RN, OCN


Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis

Alyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.

Michelle T. Chi, MD


Bring A Nuanced Approach to Venous Thromboembolism Management

Understanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.

Kellie Zeichner, BSN, RN, OCN


Kellie Zeichner Speaks to the Power of Standardized Monitoring Procedures for Patients With Rare Tumors

Kellie Zeichner BSN, RN, OCN, explains how her institution created a standardized monitoring procedure for insulinoma care.

Jack Kain, PharmD


Does the CDC’s Proposed Opioid Prescribing Guideline Fall Short on Drug Testing?

Although the CDC has put forth a strong effort to improve its opioid guidelines, many providers still feel that more can be done.

Laurel Sopher


Oncology Nurse Shares Inspiring Story of Hope

Laurel Sopher was diagnosed with breast cancer while pregnant at 15 weeks. Laurel's son, Alexander, was born in 2000. Laurel also delivered twin boys in 2004.

Pearman Parker, PhD, MPH, RN


Connecting All the Pieces: Helping Patients Make Sense of Their Chemotherapy

Chemotherapy education is a puzzle personalized for each patient. Each piece of the puzzle represents a different method of instruction to supplement nurses’ interpersonal teaching.

© 2023 MJH Life Sciences

All rights reserved.